NCT00010153View on ClinicalTrials.gov

ICI 182780 in Treating Women With Stage I or Stage II Primary Breast Cancer

PHASE3TerminatedINTERVENTIONAL
Timeline

Start Date

November 30, 2000

Primary Completion Date

October 31, 2001

Conditions
Breast Cancer
Interventions
DRUG

fulvestrant

PROCEDURE

conventional surgery

Trial Locations (1)

M20 4BX

Christie Hospital N.H.S. Trust, Manchester

Sponsors
All Listed Sponsors
collaborator

Breast International Group

OTHER

lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

NCT00010153 - ICI 182780 in Treating Women With Stage I or Stage II Primary Breast Cancer | Biotech Hunter | Biotech Hunter